Brookfield Corp’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,367
Closed -$624K 665
2023
Q1
$624K Buy
+2,367
New +$601K ﹤0.01% 557
2022
Q4
Sell
-35,162
Closed -$6.46M 655
2022
Q3
$6.46M Buy
+35,162
New +$7M 0.02% 237
2022
Q1
Sell
-15,191
Closed -$3.9M 698
2021
Q4
$3.9M Buy
+15,191
New +$3.72M 0.02% 250
2021
Q2
Sell
-6,019
Closed -$1.13M 589
2021
Q1
$1.13M Sell
6,019
-19,400
-76% -$3.42M 0.01% 352
2020
Q4
$4.18M Buy
25,419
+12,581
+98% +$1.84M 0.02% 185
2020
Q3
$1.6M Buy
+12,838
New +$1.59M 0.01% 268

Other funds holding HCA

Brookfield Corp's HCA Position: Q2 2023 in Review

Brookfield Corp sold out of HCA Healthcare (HCA) in Q2 2023, closing a stake of 2,367 shares — an estimated $624K sold.

Brookfield Corp first reported a position in HCA in Q3 2020 and held it in 6 quarters. The position peaked at $6.46M in Q3 2022. 1,012 funds tracked by Wall St. Rank hold HCA as of Q2 2023.

  • Brookfield Corp reported no remaining HCA Healthcare position as of Q2 2023 after selling out during the quarter.
  • Brookfield Corp sold 2,367 HCA Healthcare shares in Q2 2023, an estimated $624K.
  • Brookfield Corp first reported a position in HCA Healthcare in Q3 2020 and held it in 6 quarters.
  • Brookfield Corp's HCA Healthcare position peaked at $6.46M in Q3 2022.
  • 1,012 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.